Similarly, the expression of IL2RG (CD132) was significantly elevated in severe COVID-19 patients (p < 0.001), whereas IL2RB (CD122) expression remained largely unchanged across the groups (Figure 4A). This evidence concerns the gene IL2RG and COVID-19.